CClinicalTrials.gg
CompletedNCT00786929Updated Feb 4, 2009

Acute Pancreatitis and Acute Fluid Collections

A Phase 4 interventional study of Catheter drainage and Conservative treatment in Pancreatitis, sponsored by University Medical Center, Tuzla. Completed at 1 site in Bosnia and Herzegovina. Per ClinicalTrials.gov, last updated 2009-02-04.

Sponsored by University Medical Center, Tuzla · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
63
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this study is to evaluate if percutaneous drainage of sterile fluid collections recurring after initial aspiration in acute pancreatitis yielded better results than their conservative management.

02

Conditions studied

  • Pancreatitis

Browse trials for

Keywords

  • Conversion to more aggressive treatment of recurrent fluid collection
03

In context

Pancreatitis

752 studies on the registry are indexed under Pancreatitis; 181 are open to participants now.

This study's enrollment of 63 is below the median of 80 across 448 interventional studies indexed under Pancreatitis.

Browse Pancreatitis studies →

Lead sponsor

University Medical Center, Tuzla is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Symptoms and signs of acute pancreatitis and if pancreatic or/and peripancreatic fluid collections were confirmed by ultrasound and computed tomography examination

Exclusion criteria

Exclusion Criteria:

  • Collections resulting from pancreatic surgery, chronic pancreatitis and encapsulated collections and collections with uncertainty about the relationship between the collections and clinical symptoms and signs of acute pancreatitis were excluded.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    drainage

    Procedure: Catheter drainage

  • Active comparator
    2

    Conservative treatment

    Drug: Conservative treatment

Interventions

  • ProcedureCatheter drainage
  • DrugConservative treatment
06

What researchers measure

Primary outcomes

  1. Conversion to more aggressive procedure

    Time frame: Sep 2007

Secondary outcomes

  1. Number of patients turning culture positive, length of hospital stay, catheter dwell time, catheter problems and changes per patient

    Time frame: Oct 2007

07

Study locations

1 site
  • University Clinical Center
    Tuzla, TK 75000, Bosnia and Herzegovina
08

References and documents

Publications

  • Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Ann Chir. 1993;47(6):537-41. No abstract available. PubMed 8105746 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00786929
Lead sponsor
University Medical Center, Tuzla
First posted
Nov 6, 2008
Start date
Mar 2003
Primary completion
Feb 2007
Completion
Dec 2007
Last update
Feb 4, 2009

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion